Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tiechao Li is active.

Publication


Featured researches published by Tiechao Li.


Bioorganic & Medicinal Chemistry Letters | 2003

Aryl[a]pyrrolo[3,4-c]carbazoles as selective cyclin D1-CDK4 inhibitors

Concha Sanchez-Martinez; Chuan Shih; Margaret M. Faul; Guoxin Zhu; Michael Paal; Carmen Somoza; Tiechao Li; Christine A. Kumrich; Leonard L. Winneroski; Zhou Xun; Harold B. Brooks; Bharvin Patel; Richard M. Schultz; Tammy B. DeHahn; Charles D. Spencer; Scott A. Watkins; Eileen L. Considine; Jack Dempsey; Catherine A. Ogg; Robert M. Campbell; Bryan A. Anderson; Jill R. Wagner

The synthesis of new analogues of Arcyriaflavin A in which one indole ring is replaced by an aryl or heteroaryl ring is described. These new series of aryl[a]pyrrolo[3,4-c]carbazoles were evaluated as inhibitors of Cyclin D1-CDK4. A potent and selective D1-CDK4 inhibitor, 7a (D1-CDK4 IC(50)=45 nM), has been identified. The potency, selectivity profile against other kinases, and structure-activity relationship (SAR) trends of this class of compounds are discussed.


Bioorganic & Medicinal Chemistry Letters | 2003

Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides

Concha Sanchez-Martinez; Chuan Shih; Guoxin Zhu; Tiechao Li; Harold B. Brooks; Bharvin Patel; Richard M. Schultz; Tammy B. DeHahn; Charles D. Spencer; Scott A. Watkins; Catherine A. Ogg; Eileen L. Considine; Jack Dempsey; Faming Zhang

A series of indolo[2,3-a]pyrrolo[3,4-c]carbazoles and their bis-indolylmaleimides precursors have been prepared in order to compare their activity as D1-CDK4 inhibitors. Both enzymatic and antiproliferative assays have shown that the structurally more constrained indolo[2,3-a]pyrrolo[3,4-c]carbazoles are consistently more active (8-42-fold) in head-to-head comparison with their bis-indolylmaleimides counterparts. Cell-cycle analysis using flow cytometry have also shown that the indolocarbazoles are selective G1 blockers while the bis-indolylmaleimides arrest cells in the G2/M phase.


Bioorganic & Medicinal Chemistry Letters | 1998

Novel 1,3-disubstituted-5,10-dihydro-5,10-dioxo-1H-mbenzo[g]isochromene-3-carboxamides as potent antitumor agents

Wuyi Wang; Tiechao Li; Robert Milburn; J. Yates; E. Hinnant; Micheal J. Luzzio; Stuart A. Noble; Giorgio Attardo

Novel antitumor 5,10-dihydro-5,10-dioxo-1H- benzo[g]isochromene-3-carboxamides were discovered.


Tetrahedron Letters | 1998

Dehydrogenation by air: Preparation of 1,3-disubstituted-5,1-dioxo-5,10-dihydro-1H-benzo[g] isochromene scaffold

Wuyi Wang; Tibor Breining; Tiechao Li; Robert Milburn; Giorgio Attardo

Naphthaquinopyrans 5a-d, 10 and 12 have been converted to benzoisochromene IIb via base-promoted air oxidation. A mechanism is proposed to account for the observed results. Use of peroxide scavenger was found necessary for consistent yields. IIb proved to be a versatile scaffold for diversity expansion.


Journal of Medicinal Chemistry | 2003

Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors

Guoxin Zhu; Scott Eugene Conner; Xun Zhou; Chuan Shih; Tiechao Li; Bryan D. Anderson; Harold B. Brooks; Robert M. Campbell; Eileen L. Considine; Jack Dempsey; Margaret M. Faul; Cathy Ogg; Bharvin Patel; Richard M. Schultz; Charles D. Spencer; Beverly A. Teicher; Scott A. Watkins


Bioorganic & Medicinal Chemistry Letters | 2008

Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties

Mary M. Mader; Alfonso De Dios; Chuan Shih; Rosanne Bonjouklian; Tiechao Li; Wesley White; Beatriz López de Uralde; Concepcion Sanchez-Martinez; Miriam del Prado; Carlos Jaramillo; Eugenio de Diego; Luisa M. Martín Cabrejas; Carmen Dominguez; Carlos Montero; Timothy Alan Shepherd; Robert Dean Dally; John E. Toth; Arindam Chatterjee; Sehila Pleite; Jaime Blanco-Urgoiti; Leticia Perez; Mario Barberis; María José Lorite; Enrique Jambrina; C. Richard Nevill; Paul Lee; Richard C. Schultz; Jeffrey A. Wolos; Li C. Li; Robert M. Campbell


Journal of Medicinal Chemistry | 2004

Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents

Karen Lynn Lobb; Philip Arthur Hipskind; James A. Aikins; Enrique Alvarez; § Yiu-Yin Cheung; Eileen L. Considine; Alfonso De Dios; Gregory L. Durst; Rafael Ferritto; Cora Sue Grossman; Deborah D. Giera; Beth A. Hollister; Zhongping Huang; Philip W. Iversen; Kevin L. Law; Tiechao Li; Ho-Shen Lin; Beatriz López; Jose Eduardo Lopez; Luisa M. Martín Cabrejas; Denis J. McCann; Victoriano Molero; John Reilly; Michael Enrico Richett; Chuan Shih; Beverly A. Teicher; James H. Wikel; and Wesley T. White; Mary M. Mader


Archive | 2000

Agents and methods for the treatment of proliferative diseases

Rima Al-awar; Kyle Andrew Hecker; James E. Ray; Jianping Huang; Sajan Joseph; Tiechao Li; Michael Paal; Radhakrishnan Rathnachalam; Chuan Shih; Philip Parker Waid; Xun Zhou; Guoxin Zhu


Archive | 1999

Fumagillin analogs and their use as angiogenesis inhibitors

Serge Lamothe; Giorgio Attardo; Denis Labrecque; Marc Courchesne; Wuyi Wang; Tiechao Li


Archive | 2004

Ureido-pyrazole derivatives and their use as kinase inhibitors

Dios Alfonso De; Tiechao Li; Luisa Maria Martin-Cabrejas; Mark Andrew Pobanz; Chuan Shih; Yong Wang; Boyu Zhong

Collaboration


Dive into the Tiechao Li's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge